It was recently announced that Singapore-based SCG Cell Therapy, and Germany-based Formycon, have entered into a collaboration and license agreement for the development and commercialisation of Covid-19 drug FYB207. Christy Ma, Chief Strategy Officer, SCG Cell Therapy shares SCG’s recent collaboration with Germany-based Formycon for the development and commercialisation of Covid-19 drug FYB207, and how it differs from other experimental antiviral pills made by their competitors.

It was recently announced that Singapore-based SCG Cell Therapy, and Germany-based Formycon, have entered into a collaboration and license agreement for the development and commercialisation of Covid-19 drug FYB207. Christy Ma, Chief Strategy Officer, SCG Cell Therapy shares SCG&rsquo;s recent collaboration with Germany-based Formycon for the development and commercialisation of Covid-19 drug FYB207, and how it differs from other experimental antiviral pills made by their competitors.

Get a head start to your work day with Ryan Huang, Emaad Akhtar and Audrey Siek from 6am to 9am. 

Listen to insightful discussions on the stories and issues that matter the most to you and be apprised of the markets and the companies to watch.

Get a head start to your work day with Ryan Huang, Emaad Akhtar and Audrey Siek from 6am to 9am. 
Listen to insightful discussions on the stories and issues that matter the most to you and be apprised of the markets and the companies to watch.

Breakfast with Ryan Huang, Emaad Akhtar and Audrey Siek

Get a head start on your workday with Ryan Huang, Emaad Akhtar and Audrey Siek from 6 am to 9 am. 

Listen to insightful discussions on the stories and issues that matter the most to you and be apprised of the markets and the companies to watch.

Get a head start on your workday with Ryan Huang, Emaad Akhtar and Audrey Siek from 6 am to 9 am. 
Listen to insightful discussions on the stories and issues that matter the most to you and be apprised of the markets and the companies to watch.

Advertisement